A major Japanese securities firm maintained its rating on Mani at Neutral while lowering its target price to ¥1,400. As of the previous day, the consensus rating was 4 and the consensus target price was ¥1,853.
A major Japanese securities firm reportedly maintained its rating on Mani at Neutral on 23 October. At the same time, the target price was indicated as having been lowered to ¥1,400.
As of the previous day, 22 October, the rating consensus was 4, a slightly bullish level, based on 4 analysts. The target price consensus was ¥1,853, also based on 4 analysts.
The article lists Daiken Medical, Asahi Intecc, Nagaileben and Nipro as related stocks, along with information on stocks other than Mani.